Research programme: selective estrogen receptor modulators - Eisai/Radius

Alternative Names: ER-306323; ER-308698; SERMs research programme - Eisai/Radius

Latest Information Update: 25 May 2010

Price : $50 ^*

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

Discontinued CNS disorders; Menopausal syndrome; Postmenopausal osteoporosis

30 Jan 2008 RAD 1901 has moved into clinical development for the treatment of hot flushes
29 Jun 2006 Radius has licensed exclusive rights to SERMs worldwide, excluding Japan
06 Sep 2004 Preclinical trials in CNS disorders in Japan (Intraperitoneal)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com